{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:06:48Z","timestamp":1791245208531,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006736","name":"Universitetssjukhuset \u00d6rebro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006736","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009228","name":"Region \u00d6rebro l\u00e4n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009228","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.vaccine.2023.04.016","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T17:30:55Z","timestamp":1681407055000},"page":"3128-3136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Improved plasmablast response after repeated pneumococcal revaccinations following primary immunization with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1541-3345","authenticated-orcid":false,"given":"Magdalena","family":"K\u00e4ttstr\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8996-2612","authenticated-orcid":false,"given":"Bertil","family":"Uggla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"Tina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Kimby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torbj\u00f6rn","family":"Nor\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8730-6955","authenticated-orcid":false,"given":"Simon","family":"Athlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2023.04.016_b0005","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1182\/blood-2015-03-567388","article-title":"Perturbation of the normal immune system in patients with CLL","volume":"126","author":"Forconi","year":"2015","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.vaccine.2023.04.016_b0010","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1002\/cncr.29438","article-title":"Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: Natural history, clinical correlates, and outcomes","volume":"121","author":"Parikh","year":"2015","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.vaccine.2023.04.016_b0015","doi-asserted-by":"crossref","DOI":"10.3390\/cells9112398","article-title":"Chronic Lymphocytic Leukemia-Induced Humoral Immunosuppression: A Systematic Review","volume":"9","author":"Grywalska","year":"2020","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.vaccine.2023.04.016_b0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hon.2323","article-title":"Secondary immunodeficiency in lymphoproliferative malignancies","volume":"34","author":"Friman","year":"2016","journal-title":"Hematol Oncol"},{"issue":"5","key":"10.1016\/j.vaccine.2023.04.016_b0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051825","article-title":"Immune Response Dysfunction in Chronic Lymphocytic Leukemia: Dissecting Molecular Mechanisms and Microenvironmental Conditions","volume":"21","author":"Arruga","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.vaccine.2023.04.016_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.686768","article-title":"BTK Inhibitors in Chronic Lymphocytic Leukemia: Biological Activity and Immune Effects","volume":"12","author":"Palma","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2023.04.016_b0035","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.blre.2018.03.004","article-title":"Chronic lymphocytic leukemia and infection risk in the era of targeted therapies: Linking mechanisms with infections","volume":"32","author":"Hilal","year":"2018","journal-title":"Blood Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2023.04.016_b0040","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.beha.2009.12.004","article-title":"Infectious complications of chronic lymphocytic leukaemia: pathogenesis, spectrum of infection, preventive approaches","volume":"23","author":"Morrison","year":"2010","journal-title":"Best Pract Res Clin Haematol"},{"issue":"3","key":"10.1016\/j.vaccine.2023.04.016_b0045","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/cid\/ciaa090","article-title":"Differences and Temporal Changes in Risk of Invasive Pneumococcal Disease in Adults with Hematological Malignancies: Results from a Nationwide 16-Year Cohort Study","volume":"72","author":"Andersen","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"25","key":"10.1016\/j.vaccine.2023.04.016_b0050","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1016\/j.vaccine.2018.05.012","article-title":"Pneumococcal conjugate vaccine triggers a better immune response than pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia A randomized study by the Swedish CLL group","volume":"36","author":"Svensson","year":"2018","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2023.04.016_b0055","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.vaccine.2007.10.053","article-title":"Antibody response to 7-valent conjugated pneumococcal vaccine in patients with chronic lymphocytic leukaemia","volume":"26","author":"Sinisalo","year":"2007","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2023.04.016_b0060","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1080\/21645515.2019.1627160","article-title":"Antibody response to the 23-valent pneumococcal polysaccharide vaccine after conjugate vaccine in patients with chronic lymphocytic leukemia","volume":"15","author":"Lindstrom","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"10.1016\/j.vaccine.2023.04.016_b0065","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41375-020-0884-z","article-title":"Response to the conjugate pneumococcal vaccine (PCV13) in patients with chronic lymphocytic leukemia (CLL)","volume":"35","author":"Mauro","year":"2021","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.vaccine.2023.04.016_b0070","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/bjh.14855","article-title":"Lack of adequate pneumococcal vaccination response in chronic lymphocytic leukaemia patients receiving ibrutinib","volume":"182","author":"Andrick","year":"2018","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.vaccine.2023.04.016_b0075","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1182\/bloodadvances.2021004629","article-title":"Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients","volume":"5","author":"Vijenthira","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.vaccine.2023.04.016_b0080","doi-asserted-by":"crossref","unstructured":"Mikulska M, Cesaro S, de Lavallade H, Di Blasi R, Einarsdottir S, Gallo G, et al. Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7). Lancet Infect Dis. 2019;19(6):e188-e99.","DOI":"10.1016\/S1473-3099(18)30601-7"},{"key":"10.1016\/j.vaccine.2023.04.016_b0085","doi-asserted-by":"crossref","unstructured":"Cordonnier C, Einarsdottir S, Cesaro S, Di Blasi R, Mikulska M, Rieger C, et al. Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7). Lancet Infect Dis. 2019;19(6):e200-e12.","DOI":"10.1016\/S1473-3099(18)30600-5"},{"key":"10.1016\/j.vaccine.2023.04.016_b0090","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3389\/fimmu.2018.00683","article-title":"Chronic Lymphocytic Leukemia B-Cell Normal Cellular Counterpart: Clues From a Functional Perspective","volume":"9","author":"Darwiche","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2023.04.016_b0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.690328","article-title":"B-Cell Immunophenotyping to Predict Vaccination Outcome in the Immunocompromised - A Systematic Review","volume":"12","author":"Diks","year":"2021","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2023.04.016_b0100","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1080\/08820139.2021.1903033","article-title":"B Cell Response to Vaccination","volume":"50","author":"Luo","year":"2021","journal-title":"Immunol Invest"},{"issue":"1","key":"10.1016\/j.vaccine.2023.04.016_b0105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/cyto.a.22355","article-title":"Tracking plasma cell differentiation and survival","volume":"85","author":"Roth","year":"2014","journal-title":"Cytometry A"},{"issue":"12","key":"10.1016\/j.vaccine.2023.04.016_b0110","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1038\/s41375-018-0164-3","article-title":"Residual normal B-cell profiles in monoclonal B-cell lymphocytosis versus chronic lymphocytic leukemia","volume":"32","author":"Criado","year":"2018","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.vaccine.2023.04.016_b0115","doi-asserted-by":"crossref","first-page":"e114966","DOI":"10.1371\/journal.pone.0114966","article-title":"Antibody and plasmablast response to 13-valent pneumococcal conjugate vaccine in chronic lymphocytic leukemia patients\u2013preliminary report","volume":"9","author":"Pasiarski","year":"2014","journal-title":"PLoS One"},{"issue":"35","key":"10.1016\/j.vaccine.2023.04.016_b0120","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1016\/j.vaccine.2013.04.084","article-title":"Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older","volume":"31","author":"Jackson","year":"2013","journal-title":"Vaccine"},{"issue":"30","key":"10.1016\/j.vaccine.2023.04.016_b0125","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1016\/j.vaccine.2016.04.093","article-title":"Immunogenicity and safety of a second administration of 13-valent pneumococcal conjugate vaccine 5 years after initial vaccination in adults 50 years and older","volume":"34","author":"Frenck","year":"2016","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2023.04.016_b0130","doi-asserted-by":"crossref","first-page":"9199","DOI":"10.1038\/s41598-021-88491-2","article-title":"Methotrexate reduces circulating Th17 cells and impairs plasmablast and memory B cell expansions following pneumococcal conjugate immunization in RA patients","volume":"11","author":"Nived","year":"2021","journal-title":"Sci Rep"},{"issue":"20","key":"10.1016\/j.vaccine.2023.04.016_b0135","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/j.vaccine.2010.02.088","article-title":"Peak frequencies of circulating human influenza-specific antibody secreting cells correlate with serum antibody response after immunization","volume":"28","author":"Halliley","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.04.016_b0140","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.2147\/CIA.S220423","article-title":"Immunogenicity And Safety Of The 13-Valent Pneumococcal Conjugate Vaccine In Patients With Monoclonal Gammopathy Of Undetermined Significance - Relationship With Selected Immune And Clinical Parameters","volume":"14","author":"Pasiarski","year":"2019","journal-title":"Clin Interv Aging"},{"issue":"24","key":"10.1016\/j.vaccine.2023.04.016_b0145","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1016\/j.vaccine.2011.03.087","article-title":"Antibody forming cells and plasmablasts in peripheral blood in CVID patients after vaccination","volume":"29","author":"Chovancova","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2023.04.016_b0150","article-title":"Age and Primary Vaccination Background Influence the Plasma Cell Response to Pertussis Booster Vaccination","volume":"10","author":"Diks","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"42","key":"10.1016\/j.vaccine.2023.04.016_b0155","doi-asserted-by":"crossref","first-page":"6253","DOI":"10.1016\/j.vaccine.2018.08.069","article-title":"Pneumococcal vaccination in adult solid organ transplant recipients: A review of current evidence","volume":"36","author":"Dendle","year":"2018","journal-title":"Vaccine"},{"issue":"13\u201314","key":"10.1016\/j.vaccine.2023.04.016_b0160","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/S0264-410X(00)00409-6","article-title":"Antibody responses to pneumococcal and haemophilus vaccinations in patients with B-cell chronic lymphocytic leukaemia","volume":"19","author":"Hartkamp","year":"2001","journal-title":"Vaccine"},{"issue":"44","key":"10.1016\/j.vaccine.2023.04.016_b0165","doi-asserted-by":"crossref","first-page":"6859","DOI":"10.1016\/j.vaccine.2020.08.065","article-title":"Serum IgG2 levels predict long-term protection following pneumococcal vaccination in systemic lupus erythematosus (SLE)","volume":"38","author":"Gerard","year":"2020","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2023.04.016_b0170","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1046\/j.1365-2249.1999.01077.x","article-title":"Contribution of serotype-specific IgG concentration, IgG subclasses and relative antibody avidity to opsonophagocytic activity against Streptococcus pneumoniae","volume":"118","author":"Anttila","year":"1999","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2023.04.016_b0175","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1182\/blood.2021014085","article-title":"Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination","volume":"139","author":"Herishanu","year":"2022","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.vaccine.2023.04.016_b0180","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/ajh.23214","article-title":"Monoclonal B-cell lymphocytosis (MBL) with normal lymphocyte counts is associated with decreased numbers of normal circulating B-cell subsets","volume":"87","author":"Hauswirth","year":"2012","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.vaccine.2023.04.016_b0185","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.hoc.2013.01.003","article-title":"Understanding the immunodeficiency in chronic lymphocytic leukemia: potential clinical implications","volume":"27","author":"Riches","year":"2013","journal-title":"Hematol Oncol Clin North Am"},{"issue":"4","key":"10.1016\/j.vaccine.2023.04.016_b0190","doi-asserted-by":"crossref","first-page":"e1417720","DOI":"10.1080\/2162402X.2017.1417720","article-title":"Dynamic changes of the normal B lymphocyte repertoire in CLL in response to ibrutinib or FCR chemo-immunotherapy","volume":"7","author":"Schliffke","year":"2018","journal-title":"Oncoimmunology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23003997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23003997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:26:34Z","timestamp":1759404394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23003997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":38,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0264410X23003997"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.04.016","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved plasmablast response after repeated pneumococcal revaccinations following primary immunization with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}